nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—midbrain—Gilles de la Tourette syndrome	0.057	0.0822	CbGeAlD
Pentoxifylline—NT5E—nervous system—Gilles de la Tourette syndrome	0.0468	0.0676	CbGeAlD
Pentoxifylline—NT5E—central nervous system—Gilles de la Tourette syndrome	0.0451	0.0651	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—Gilles de la Tourette syndrome	0.0401	0.0579	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—Gilles de la Tourette syndrome	0.0386	0.0557	CbGeAlD
Pentoxifylline—NT5E—brain—Gilles de la Tourette syndrome	0.0358	0.0517	CbGeAlD
Pentoxifylline—ADORA1—midbrain—Gilles de la Tourette syndrome	0.035	0.0506	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—Gilles de la Tourette syndrome	0.0334	0.0482	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—Gilles de la Tourette syndrome	0.0321	0.0464	CbGeAlD
Pentoxifylline—ADORA2B—brain—Gilles de la Tourette syndrome	0.0307	0.0442	CbGeAlD
Pentoxifylline—PDE5A—nervous system—Gilles de la Tourette syndrome	0.0304	0.0439	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—Gilles de la Tourette syndrome	0.0293	0.0422	CbGeAlD
Pentoxifylline—ADORA1—nervous system—Gilles de la Tourette syndrome	0.0288	0.0416	CbGeAlD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0278	0.0905	CbGpPWpGaD
Pentoxifylline—ADORA1—central nervous system—Gilles de la Tourette syndrome	0.0277	0.04	CbGeAlD
Pentoxifylline—PDE4A—brain—Gilles de la Tourette syndrome	0.0273	0.0394	CbGeAlD
Pentoxifylline—PDE4B—midbrain—Gilles de la Tourette syndrome	0.0259	0.0374	CbGeAlD
Pentoxifylline—ADORA2A—brain—Gilles de la Tourette syndrome	0.0255	0.0368	CbGeAlD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0236	0.0769	CbGpPWpGaD
Pentoxifylline—PDE5A—brain—Gilles de la Tourette syndrome	0.0232	0.0335	CbGeAlD
Pentoxifylline—ADORA1—brain—Gilles de la Tourette syndrome	0.022	0.0318	CbGeAlD
Pentoxifylline—PDE4B—nervous system—Gilles de la Tourette syndrome	0.0213	0.0308	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—Gilles de la Tourette syndrome	0.0205	0.0296	CbGeAlD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0182	0.0594	CbGpPWpGaD
Pentoxifylline—PDE4B—brain—Gilles de la Tourette syndrome	0.0163	0.0235	CbGeAlD
Pentoxifylline—ADORA2A—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0147	0.0478	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00691	0.0225	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00671	0.0218	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—HDC—Gilles de la Tourette syndrome	0.00566	0.0184	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00475	0.0155	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00461	0.015	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00457	0.0149	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00444	0.0145	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00438	0.0142	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00429	0.014	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00419	0.0136	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00413	0.0135	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00407	0.0132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00392	0.0128	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00389	0.0127	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0038	0.0124	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00379	0.0123	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00377	0.0123	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00367	0.0119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00356	0.0116	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00354	0.0115	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00352	0.0114	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00333	0.0108	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00331	0.0108	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00323	0.0105	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00301	0.00981	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.003	0.00977	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00298	0.00971	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00291	0.00949	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0029	0.00943	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0029	0.00943	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00271	0.00884	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0027	0.00878	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00257	0.00837	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00254	0.00826	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0025	0.00813	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00248	0.00808	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00246	0.00802	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00246	0.00802	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00233	0.00757	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00229	0.00747	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00687	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00196	0.00638	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0019	0.00619	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0019	0.00619	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00189	0.00615	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00177	0.00577	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00169	0.00549	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00164	0.00533	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00163	0.0053	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00161	0.00523	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00153	0.00498	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00153	0.00498	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00152	0.00496	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00149	0.00484	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00149	0.00484	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00143	0.00467	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00142	0.00461	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00139	0.00453	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00139	0.00453	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00138	0.00451	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00138	0.00451	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00137	0.00448	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00135	0.00439	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0013	0.00424	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0013	0.00422	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00129	0.00419	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00128	0.00417	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00126	0.00411	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00126	0.00409	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00125	0.00407	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00124	0.00404	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00118	0.00383	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00116	0.00379	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00111	0.0036	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00107	0.0035	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00348	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.001	0.00327	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.001	0.00326	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000976	0.00318	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00097	0.00316	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00097	0.00316	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000909	0.00296	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000908	0.00296	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000904	0.00294	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000897	0.00292	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00088	0.00287	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000878	0.00286	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000824	0.00268	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000821	0.00267	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000818	0.00266	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000815	0.00265	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000797	0.0026	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000769	0.0025	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00076	0.00247	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000746	0.00243	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000743	0.00242	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000738	0.0024	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000701	0.00228	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000695	0.00226	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000687	0.00224	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000637	0.00207	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000594	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000576	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000573	0.00187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000537	0.00175	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000521	0.0017	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00052	0.00169	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000487	0.00159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000481	0.00157	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000376	0.00122	CbGpPWpGaD
